IRadimed Corporation
IRMD
$96.49
$0.230.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.52% | -3.42% | 23.18% | -8.93% | 1.93% |
| Total Depreciation and Amortization | -0.78% | 84.92% | 6.90% | -0.56% | -1.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 279.57% | 159.67% | -79.20% | 244.47% | -41.95% |
| Change in Net Operating Assets | -1,871.81% | -84.69% | 170.12% | -1,074.14% | -93.18% |
| Cash from Operations | -15.22% | -9.81% | 80.48% | -28.30% | -34.33% |
| Capital Expenditure | 74.14% | 56.84% | 28.72% | -32.52% | 26.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.94% | 33.03% | 14.47% | 17.62% | -32.41% |
| Cash from Investing | 67.05% | 55.25% | 27.92% | -28.15% | 23.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -7,735.14% | 69.17% | 17.45% | 78.55% | -2,946.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -295.56% | -0.05% | 0.00% | -13.71% | -0.02% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -396.00% | 2.90% | 0.89% | 5.78% | -26.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -252.03% | 32.48% | 240.04% | -470.88% | -83.89% |